Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-25-046217
Filing Date
2025-03-28
Accepted
2025-03-27 17:44:56
Documents
75
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 10-K bcab-20241231.htm   iXBRL 10-K 2836834
2 EX-4.3 bcab-ex4_3.htm EX-4.3 56082
3 EX-19.1 bcab-ex19_1.htm EX-19.1 77303
4 EX-23.1 bcab-ex23_1.htm EX-23.1 6372
5 EX-31.1 bcab-ex31_1.htm EX-31.1 14692
6 EX-31.2 bcab-ex31_2.htm EX-31.2 14695
7 EX-32.1 bcab-ex32_1.htm EX-32.1 10138
8 GRAPHIC img68418186_0.jpg GRAPHIC 108982
  Complete submission text file 0000950170-25-046217.txt   10797884

Data Files

Seq Description Document Type Size
9 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT bcab-20241231.xsd EX-101.SCH 1454954
78 EXTRACTED XBRL INSTANCE DOCUMENT bcab-20241231_htm.xml XML 1722922
Mailing Address 11085 TORREYANA ROAD SAN DIEGO CA 92121
Business Address 11085 TORREYANA ROAD SAN DIEGO CA 92121 858-558-0708
BioAtla, Inc. (Filer) CIK: 0001826892 (see all company filings)

EIN.: 851922320 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-39787 | Film No.: 25780785
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)